All Articles tagged infliximab
- Gastrointestinal Conditions
November 20, 2023 EDT This study describes persistence and dose titration among patients with Crohn's disease with 3 years of follow-up. Patients initiating ustekinumab had the highest persistence rate and lowest dose escalation rate.